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Abstract: Stromal Derived Factor-1 (SDF-1)-CXCR4 axis plays a pivotal role in biology and metastasis of several tumors.
The aim of this study was to see if SDF-1 alone or in combination with Hepatocyte Growth Factor (HGF) affects biology of
human cervical carcinoma (HCC) cells. We found that HCC cell lines investigated in our study highly express CXCR4 on their
surface. CXCR4 was also expressed on tumor cells in tissue sections derived from cervical cancer patients. At the same time
normal cervical epithelium was negative for CXCR4 expression what suggests a strong correlation between CXCR4 and
malignant cell phenotype. Subsequently, we studied a potential role of the SDF-1-CXCR4 axis in HCC and noticed that SDF-1
(i) chemoattracted HCC cells, (ii) enhanced their scattering, (iii) stimulated nuclear localization of β-catenins and upregulated
their target gene cyclin D1 and (iv) at the molecular level induced calcium flux and activated RAS-MAPK, PI3-AKT and
JAK-STAT pathways. SDF-1-mediated functions were additionally enhanced in the presence of HGF. Thus, our data show
that the SDF-1-CXCR4 axis affects biology of HCC cells. Furthermore, we postulate that this axis might become a potential
target to prevent progression of cervical cancer. 
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Introduction
Cervical carcinoma is a major cause of tumor-related
deaths among women around the world and there are
approximately five hundred thousand new incidents of
this cancer each year worldwide [21, 23]. The cervical
tumors vary in their invasiveness from non-metastatic
tumors growing in situ to highly metastatic ones infil-
trating neighboring tissues and distant organs [26].
Human cervical carcinoma metastasizes frequently to
the lymph nodes, bones, liver and lungs. Thus, elucida-
tion of mechanisms that lead to the spread of HCC may
be important in developing antimetastatic therapeutic
strategies.
Recently, SDF-1 - G protein-coupled seven trans-
membrane span receptor CXCR4 axis had been identi-
fied to play an important role in metastasis of several
CXCR4-positive solid tumors such as breast cancer [18],
ovarian cancer [24], lung cancer [13], prostate cancer
[28], neuroblastoma [9], glioma [1] and rhabdomyosar-
coma [12, 15]. Activation of CXCR4 on these tumors
activates several processes that are essential for meta-
static behavior of cancer cells (e.g., motility, adhesion,
secretion of metalloproteinases and angiopoietic fac-
tors). More importantly, CXCR4-positive tumor cells
are chemoattracted and metastasize to organs that highly
express SDF-1 (e.g, bones, lymph nodes, liver and
lungs). However, no studies were reported yet on a
potential role of the SDF-1-CXCR4 axis in regulating
biology and metastasis of cervical carcinomas. The only
relevant paper evaluated the activity of CXCR4 pro-
moter in human cervical carcinoma cells. The authors
found that this promoter possessed high activity in HCC
cells [22].
In contrast to the SDF-1-CXCR4 axis, the role of
HGF and its receptor MET in regulating metastatic
behavior of HCC has been well established [25]. HGF
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that binds to tyrosine kinase receptor MET was found to
stimulate proliferation and scattering of cervical carcinoma
cells due to disruption of intercellular junctions, skeletal
reorganization and enhancement of cell motility/migration
[4, 25]. In our recent studies we noticed that SDF-1 and
HGF may in a synergistic way influence the metastatic
behavior of human rhabdomyosarcoma cells [12], sugges-
ting that both factors may be involved in the spread of solid
tumors that express CXCR4 and MET receptors.
In this study we asked if the SDF-1-CXCR4 axis
alone or in synergy with HGF-MET receptor is involved
in metastasis of HCC. To address this issue we pheno-
typed (i) established HCC, (ii) tumor samples obtained
from patients suffering from metastatic cervical carci-
noma, and (iii) cervical epithelium from normal healthy
donors for CXCR4 expression. We also attempted to
elucidate the role that the CXCR4-SDF-1 axis plays in
cervical carcinoma tumor progression and its potential
role in facilitating the metastatic behavior of HCC. Fi-
nally, we investigated if responsiveness of HCC to SDF-
1 gradient is enhanced in the presence of HGF. Our data
identified the CXCR4-SDF-1 axis as a potential target
for developing new antimetastatic strategies in HCC.
Materials and methods
Cell lines and tissue samples. All the cervical carcinoma cell lines
used in this study (HeLa, C33, HTB34, HTB35, CaSki, C4I) were
purchased from ATCC (Rockville, USA) and maintained in DMEM
(Gibco BRL) plus 10% FBS (Gibco BRL) at 37°C, 5% CO2 and 95%
humidity. Cervical carcinoma samples were derived from primary
tumor site of patients with metastatic disease. Normal human cervical
epithelium sample was taken during oncological resections of the
cervix. After washing, the biopsy was placed in PBS containing
dispase (12 U/mL) for 16 h at 4°C. Next, subendothelial tissue was
removed and epithelium was treated with 0.05% trypsin for 10 min
to isolate epithelial cells. The enzyme activity was eliminated by
diluting with KGM-2 medium (Sigma). The cell suspension was then
centrifuged for 5 min at 100 × g and the cell pellet was resuspended
in KGM-2 serum-free medium. After 5-6 days, the epithelial cells
were passaged and used for experiments. All experiments performed
on human tissues were approved by the Institutional Board of Jagiel-
lonian University Medical College, Cracow, Poland.
FACS analysis of CXCR4 expression. For FACS analysis cells
were harvested using sodium versenate (SV) in order to prevent
downregulation of the receptor expression after exposure to trypsin.
The cells were incubated in the presence of SV for 10-20 min and
subsequently washed with the culture medium. The cell pellet was
resuspended in staining buffer (PBS + 5% FBS) at concentration of
107/ml. 100 µl of the cell suspension was used for staining. The
CXCR4 antigen was detected with PE-anti-CXCR4 monoclonal
antibody (MoAb) (R&D Systems), clone 12G5. The cells were
incubated with 20 µl of antibody for 30 min at 4°C, washed twice in
staining buffer and fixed with 1% paraformaldahyde before analysis.
The FACS analysis was performed on FACSCalibur flow cytometer
and analyzed with CellsQuest software (BDSciences). 
Immunofluorescence staining of CXCR4. To demonstrate
presence of CXCR4 in patients’ samples, the immunofluorescence
staining was performed using frozen tissues from metastatic tumors.
Sections (3 µm) were cut in a cryostat and put on glass slides. Next,
they were fixed with ice-cold acetone and washed in PBS. The
sections were blocked with 0.5% BSA and incubated with mouse
monoclonal antibody against human CXCR4, clone 12G5 at a con-
centration of 10 µg/ml (BDSciences) for 30 min at 37°C in a humid
chamber. The sections were washed 3 times and stained with sec-
ondary anti-mouse antibody (1:200) conjugated with Alexa-488
(Molecular Probes) for 30 min at 37°C in a humid chamber. Next,
they were rinsed twice with PBS, mounted and examined using
Olympus BX51 fluorescence microscope equipped with a charge-
coupled camera (Olympus America) and analyzed with Image-Pro
software (Media Cybernetics, Inc.).
Chemotaxis studies. The chemotaxis towards SDF-1 and HGF
gradient was studied using modified Boyden’s chambers with 8-µm
pore polycarbonate membrane inserts. The membrane was covered
with 50 µl of 0.5% gelatin 10 min before the assay to facilitate cell
attachment. Gelatin solution was discarded before the assay. Cells
were detached with 0.25% trypsin, followed by inactivation with
culture medium, resuspended in DMEM medium containing 0.5%
BSA and seeded into the upper chamber of a Transwell insert (Costar
Transwell) at a density of 5×104 per 100 µl. The lower chamber was
filled with DMEM/BSA medium containing SDF and HGF at various
concentrations. DMEM/BSA medium alone was used as a negative
control. To determine whether the migration was stimulated by the
gradient of the chemoattractant, in some samples SDF was also added
into the upper chamber to equalize the difference in concentration
between chambers. After 24 h, the inserts were removed from the
transwells, cells remaining in the upper chamber were scraped off with
cotton wool and the cells that had transmigrated were stained with
Giemsa and counted under high power field (HPF). 5 fields were counted
each time and the mean number of cells per HPF was calculated. 
Proliferation assay. For the proliferation study cells were seeded in
96-well plates at 500 cell/well concentration in the culture medium.
After attachment of cells, the medium was changed and replaced with
DMEM containing 0.5% BSA and SDF-1 (10 ng/ml or 100 ng/ml),
HGF (25 ng/ml, 2.5 ng/ml, or 0.25 ng/ml) or combination of both.
Each assay was run in quadruplicate. After 72 h, 20 µl of the
CellTiter96 Aqueous One Solution Cell Proliferation Assay (Pro-
mega) was added into each well. The plates were developed for 1-4
h, read using the ELx800 Universal Microplate Reader (Bio-tech)
and analyzed using KC4 v3.0 with PowerReports software.
Western blots. Western blots were carried out on extracts prepared
from CC cell lines (1 × 107 cells) which were seeded in 6-well plates.
After cells adhered to the plastic, medium was changed and cells were
kept in DMEM medium containing 0.5% BSA to render them
quiescent. The cells were then stimulated with 100 ng/ml SDF-1β
and 10 ng/ml HGF for 2, 10, 30, 60 and 120 min at 37°C, and lysed
on ice in MPER lysing buffer (Pierce) containing protease and
phosphatase inhibitors (Sigma). Subsequently, the extracted proteins
were separated on a 10% SDS-PAGE gel and transferred to a
nitrocellulose membrane (Schleicher & Schuell) as previously de-
scribed [15]. Phosphorylation of the intracellular kinases, 44/42
MAPK (Thr 202/Tyr 204) and AKT, as well as STAT5 proteins was
detected using commercial mouse phospho-specific monoclonal
antibodies (p44/42) or rabbit phospho-specific polyclonal antibodies
(all from Cell Signaling) followed by HRP-conjugated goat anti-
mouse IgG or goat antirabbit IgG as secondary antibodies (Santa
Cruz Biotech), as described previously [15]. Equal loading in the
lanes was evaluated by stripping the blots and re-probing with
appropriate Abs against total proteins. The membranes were de-
veloped with an ECL reagent (Amersham Life Sciences), dried and
subsequently exposed to HyperFilm (Amersham).
Calcium mobilization. Cells were incubated for 30 min at 30°C with
1-2 µM Fura-2/AM (Molecular Probes). After incubation, the cells were
washed once and resuspended in loading buffer without FBS. Within 1
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h cells were stimulated with SDF-1β (10 ng/ml), HGF (10 ng/ml) or both
and analyzed using F-2500 fluorescence spectrophotometer (Hitachi).
Fluorescent staining of actin cytoskeleton and β-catenin. For the
visualization of the actin cytoskeleton and β-catenin, cells were
cultured for 12 h on glass coverslips in DMEM medium sup-
plemented with 10% fetal bovine serum. Subsequently the medium
was changed to DMEM/0.5% BSA and cells were cultured for next
12-24 h in the presence of 100 ng/ml SDF-1β, 10 ng/ml HGF or both.
Next the cells were fixed in 3.7% paraformaldehyde/Ca- and Mg-free
PBS for 15 min and permeabilized with 0.1% triton X-100 in PBS
for 1 min at RT. For actin visualization cells were stained with
Alexa488-phalloidin (Molecular Probes) at a concentration of 0.5
U/ml for 1 h. For β-catenin demonstration cells were stained with
anti-β-catenin primary mouse antibody (sc-7963; Santa Cruz) at 1:100
dilution followed by secondary anti-mouse Alexa488-conjugated anti-
body (Molecular Probes) diluted 1:200. The stained cells were examined
using Olympus BX51 fluorescence microscope equipped with a charge-
coupled camera and analyzed with Image-Pro software. 
RNA extraction and reverse transcription. Total RNA was ex-
tracted using RNeasy Mini Kit (Qiagen, Hilden, Germany) followed
by DNAse treatment (Promega, Madison, VI). The reverse polymer-
ase transcription was performed using Superscript II reverse tran-
scriptase (Invitrogen, Carlsbad, CA).
Quantitative real time PCR analysis. Cyclin D1 expression was
determined by quantitative real time PCR analysis on the 7300 Real
Time PCR System (Applied Biosystem) using a commercially avail-
able SYBR Green PCR Master Mix (Applied Biosystem) containing
AmpliTaq Gold DNA Polymerase and SYBR Green I dye. Cyclin
D1 was amplified using forward primer 5’-GCA TGT TCG TGG
CCT CTA AGA T and reverse primer 5’-GAG AAG CTG TGC ATC
TAC ACC G. Cells were seeded at low density, synchronized for 12
h in 0.5% BSA containing medium and stimulated for 24 h with
SDF-1 (100 ng/ml) and HGF (10 ng/ml) in 0 .5% BSA medium. The
mRNA expression level for all samples was normalized to the
housekeeping β-actin gene amplified with forward primer 5’-GGA
TGC AGA AGG AGA TCA CTA and reverse primer 5’-CGA TCC
ACA CGG AGT ACT TG.
Statistics. Arithmetic means and standard deviations were calculated
using Instat 1.14 (GraphPad) software. Data were analyzed using the
Student t-test for unpaired samples.
Results
The expression of CXCR4 receptor on HCC cell
lines
CXCR4 is expressed on several tumors. To address if
this receptor is also expressed in HCC, six established
human cervical carcinoma cell lines were evaluated
for CXCR4 expression. We found that all cells lines
evaluated in our study expressed CXCR4 by FACS
(Fig. 1A). At the same time, however, no CXCR4
expression was found on normal cervical epithelium
(Fig. 1B). The latter cells, however, highly expressed
CD29 on their surface.
Next, the immunofluorescent staining for CXCR4
expression was performed on tissue samples derived
from three patients with cervical cancer. We noticed that
all samples derived from HCC samples showed strong
immunostaining for CXCR4 (example in Fig. 1C). 
SDF-1 stimulates migration of HeLa and C33a
cells
The SDF-1-CXCR4 axis was reported to regulate meta-
static behavior of several tumors. We became interested if
this axis is also involved in metastasis of HCC and to assess
a role of SDF-1 in regulating the metastatic behavior of
HCC cells, we selected the HeLa cell line as a model. This
cell line highly expresses CXCR4 (Fig. 1A) in addition to
MET receptor (not shown) which binds HGF that is a
known chemoattractant for HeLa cells. We found that
HeLa cells were chemoattracted by a low concentration of
both, SDF-1 (10 ng/ml) and HGF (10 ng/ml). Furthermore,
when we employed both factors together an additive effect
was observed (Fig. 2A). Similar results were obtained with
another HCC cell line C33a (Fig. 2B). In contrast, SDF-1
at higher concentration (100 ng/ml) did not chemoattract
HCC cells (not shown). 
CXCR4 is functional on HeLa cells
We performed several assays to study if CXCR4 is
functional on HeLa cells evoking such effects as calcium
flux and phosphorylation of intracellular signaling path-
ways. Activation of calcium flux in cells is related to cell
migration/adhesion and as reported, stimulation of
CXCR4 by SDF-1 increases calcium flux in several cell
types [16, 17]. Thus, we became interested if HeLa cells
will respond to SDF-1 by calcium flux. Figure 3 shows
that SDF-1 induces calcium flux in these cells. Further-
more, HGF alone did not induce calcium flux in HeLa
cells, however, it slightly sensitized response of these
cells to stimulation by SDF-1 - as evidenced by an
enhanced calcium flux if SDF-1 and HGF were em-
ployed together (Fig. 3). 
Subsequently, we evaluated in HeLa cells the effect
of SDF-1 stimulation on phosphorylation of signaling
pathways that are relevant for cell proliferation/survival
and motility (RAS-MAPK, PI3-AKT, JAK-STAT). We
noticed that SDF-1, similarly to HGF stimulated in HeLa
cells phosphorylation of MAPK and AKT. Furthermore,
SDF-1, but not HGF, activated STAT3 (Fig. 4A). 
Since the duration of activation of intracellular path-
ways is an important factor in facilitating biological
responses, we focused on the timing of SDF-1 stimula-
tion (Fig. 4B). We found that MAPK stimulation was
strongest at 2 and 10 min after SDF-1 addition and
returned back to the baseline by 30 min. In contrast,
phosphorylation of STAT-3 persisted for 60 min and
returned to baseline only after 120 min (Fig. 4B).
SDF-1 does not stimulate proliferation of HeLa
cells
Since HeLa cells responded strongly to SDF-1 by acti-
vation of various intracellular pathways including mi-
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Fig. 1. Expression of CXCR4 on HCC cell lines, normal cervical epithelium and metastatic HCC sample. A. Flow cytometric analysis of six
HCC cell lines stained for expression of CXCR4 using 12G5 monoclonal antibodies. All cell lines expressed CXCR4 in a range between
70% to 90%. B. Normal cervical epithelium does not express CXCR4. CD29 was used as a positive control. Cytometric analysis was
performed using FACS Calibur. C. CXCR4 immunofluorescent staining of metastatic HCC tumor cells. Samples obtained from HCC patients
contained strongly positive cells. 
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togenic RAS-MAPK, we evaluated if SDF-1 can stimu-
late proliferation of these cells. The proliferation of
HeLa cells was assessed under serum free conditions by
employing MTT assay. SDF-1 was added at concentra-
tion of 10 ng/ml and 100 ng/ml and as a positive control,
HGF was employed at concentration of 25 ng/ml, 2.5
ng/ml and 0.25 ng/ml, previously shown to stimulate
proliferation of cervical carcinoma cells [5]. We did not
observe, however, any effect of SDF-1 on cell prolife-
ration, although HeLa cells proliferated in response to
HGF (data not shown).
SDF-1 and HGF stimulate HCC cell scattering
HeLa cells are growing in vitro in close contact forming
clusters visible under an inverted microscope (Fig. 5A).
Since tumor cell scattering is important for invasion, we
evaluated if SDF-1 and HGF induce scattering of these
cells. We noticed that both SDF-1 and HGF increased
scattering of HeLa cells and that this effect was dose
dependent (Fig. 5 B-I). 
F-actin reorganization after SDF-1 and HGF
stimulation
Reorganization of F-actin is essential for cell migra-
tion/adhesion. We noticed that HeLa cells stimulated
with SDF-1 (Fig. 6 B) spread from the clusters and, more
importantly, F-actin tended to accumulate at one edge of
the cell (Fig. 6). This type of F-actin organization and
polarization of cell shape followed by functional asym-
metry manifested by the formation of leading lamella is
typical for migratory cells and is often referred to as the
leading edge [30]. This effect was additionally enhanced
in the presence of HGF (Fig. 6D).
Nuclear accumulation of  β-catenins and target
gene activation 
Beta-catenin is an important component of adherent
junctions and may translocate upon stimulation from the
cell membrane into the nucleus, where it plays a role in
Fig. 2. SDF-1 enhances chemotaxis of cervical carcinoma cell lines
toward an HGF gradient. HCC showed weak chemotaxis in the
presence of low doses of SDF-1 (10 ng/ml). However, addition of
SDF-1 at low concentration to medium containing 10 ng/ml HGF
resulted in increased chemotaxis of HCC cells. Five high power
fields (HPF) were counted and the mean number of cells per HPF
was calculated.
Fig. 3. SDF-1 induces calcium flux
in HeLa cells. HeLa cells stimulated
with 100 ng/ml of SDF-1 showed a
strong increase in intracellular cal-
cium levels. HGF/SF alone did not
induce calcium flux in HeLa cells
but it sensitized cells to stimulation
with SDF-1 as observed by an en-
hanced calcium flux when both fac-
tors were employed together. 
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Fig. 4. SDF-1 activates intracellular
signaling pathways. Data was obtained
using western blot assay. A. Incuba-
tion of HCC cells with SDF-1 resulted
in phosphorylation of MAPK p44/p42,
AKT and STAT3 proteins. Activation
of MAPK and AKT was lower in com-
parison to HGF but the level of STAT3
activation was higher. B. Time course
of SDF-1 activation. MAPK phospho-
rylation peaked at 2 minutes, lasted out
to 10 minutes and returned to a control
level after 30 minutes. STAT3 activa-
tion was prolonged and was seen for
60 minutes.
Fig. 5. SDF-1 enhances scattering ef-
fect of HGF. HCC cells growing in
clusters were stimulated with a low (10
ng/ml - B, E, H) and high concentra-
tion (100 ng/ml - C, F, I) of SDF-1 as
well as low (5 ng/ml - D, E, F) and high
(10 ng/ml - G, H, I) concentration of
HGF; A - unstimulated control. SDF-1
increases scattering of HCC induced
by HGF in a dose dependent manner. 
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the activation of several genes [2, 3]. Thus, we investi-
gated the influence of SDF-1 stimulation on the pattern
of β-catenin expression in HCC cells (Fig. 7). In un-
stimulated HeLa cells, the β-catenin staining was localized
to the cell membrane (Fig. 7A). When HGF was used, the
staining became more diffuse, indicating that the cells were
losing cell to cell contact (Fig. 7B). Similar effects were
observed after SDF-1 stimulation (Fig. 7C). More im-
portantly, when both ligands were added simultaneous-
ly, β-catenins translocated to the nucleus as evidenced by
their nuclear accumulation (Fig. 7D). 
To study if translocation of β-catenins leads to the
activation of Tcl/Lef transcription factor and subsequently
to upregulation of its target genes we evaluated the effect of
Fig. 6. SDF-1 together with HGF
induces a migratory phenotype of
HCC cells. Stimulation of HCC cells
with SDF-1 (100 ng/ml - B, D) and
HGF (10 ng/ml - C, D) induces
spreading of HCC from clusters and
reorganization of F-actin that tends to
accumulate at the leading edge (ar-
rowheads); A - unstimulated control.
F-actin visualized using Alexa488-
phalloidin staining.
Fig. 7. Disruption of cell junctions and nuclear translocation of β-catenins after stimulation with both SDF-1 and HGF. HCC cells cultured
in the presence of SDF-1 (100 ng/ml) and HGF (10 ng/ml) show diminished expression of β-catenins in the cell-cell junctions and its
accumulation in the cell nuclei. Upper panel - phase contrast microscope images; lower panel - fluorescence microscope images. 
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SDF-1 stimulation on expression of cyclin D1 that is one
the known β-catenins-Tcl/Lef target genes. We found
that after 24 hours cyclin D1 expression was increased
almost two times following stimulation by SDF-1 and/or
HGF (Fig. 8).
Discussion
Cervical tumors differ in their tumorigenicity, from be-
nign non-invasive to highly malignant invading the
neighbouring tissues [26]. The role of some growth
factors and cytokines in the invasive phenotype of HCC
has already been established [32, 33]. As an example,
HGF was shown to induce the invasive phenotype in
HCC [25]. Invasion of adjacent tissues is characterised
by disruption of cell-cell junctions followed by en-
hanced cell motility and HGF was shown to enhanced
HCC scattering and motility. 
Recently, a lot of attention has been focused on the
role of chemokines and chemokine receptors in dissemi-
nation and metastasis of solid tumors [12, 15, 18]. In
particular, the role of the SDF-1-CXCR4 axis in tumor
invasion has been studied. It has been shown that ex-
pression of CXCR4 on breast cancer cells is one of
important factors affecting their metastasis to the bone
marrow [18]. There are also reports that SDF-1-CXCR4
may play a role in lymph node metastasis of oral epithe-
lium squamous cell carcinoma [31] and squamous cell
carcinoma of the tongue [6]. Our group reported recently
that SDF-1 together with HGF could play a very import-
ant role in invasion of rhabdomyosarcoma cells to the
bone marrow [12, 15].
In this paper, we studied the expression of CXCR4
on HCC-derived cell lines as well as on primary tissue
samples from patients suffering from cervical carcino-
ma. We also looked at the biological role SDF and its
receptor CXCR4 may play alone or in combination with
HGF in proliferation, chemotaxis and cytoskeletal reor-
ganization in HCC cell lines. All of these events are
crucial for tumor metastasis and progression. 
We noticed that both HCC-derived cell lines and
tissue from HCC patients express CXCR4. At the same
time CXCR4 was absent from normal epithelial cells.
This suggests that CXCR4 expression correlates with
cervical epithelium malignancy. SDF-1 was shown to
stimulate migration of normal and malignant cells [14,
15, 18]. Since the invasion is dependent on cell sensitiv-
ity to the chemokine gradient, we studied if SDF-1 can
stimulate chemotaxis of HCC cell lines. We found that
SDF-1 is able to stimulate migration of HCC cell lines
if employed at low doses, however, this effect was
absent when higher concentrations of SDF-1 were em-
ployed. This observation is in agreement with previous
reports showing dose-dependent desensitization of
chemokine receptors [11]. Furthermore, chemotaxis
correlates with an intracellular increase in calcium con-
centration that is stimulated by chemokines. Our cal-
cium flux experiments confirmed that SDF-1 is able to
stimulate calcium mobilization in HCC cells. This effect
was enhanced in the presence of HGF/SF. Similar data
were reported previously in haematopoietic cells.
Groopman et al. [8] observed an increase in calcium flux
in hematopoietic CT cells when SDF-1 and stem cell
factor were used simultaneously. Our data clearly show
that SDF-1 is a chemoattractant for HCC cells and that
SDF-1 together with HGF promotes cervical carcinoma
cell scattering.
We also demonstrated F-actin reorganization follow-
ing stimulation with both SDF-1 and HGF. We observed
accumulation of F-actin in the region of the leading edge
of stimulated cells. This type of change in intracellular
distribution of F-actin is characteristic for cells acquiring
an invasive phenotype. This enables the cells to move
by firmly attaching to the surface at the leading edge
while contracting the lagging edge [30]. To our surprise,
we also noticed changes in the surface distribution of
β-catenins and their nuclear accumulation in cells sim-
ultaneously stimulated by SDF-1 and HGF. 
Beta-catenins play a very important role in the inte-
grity of adherent junctions and are responsible for con-
necting E-cadherins to cytoskeletal proteins such as
F-actin [3]. After nuclear translocation β-catenins may
also act as transcription factors and together with the
Tcl/Lef family of transcription factors activate several
genes - c-myc, cyclin D and MDR - which are respon-
sible for tumor progression [2, 10]. Indeed, in our study
we observed upregulation of mRNA expression for cy-
clin D1 which suggests that β-catenins-Tcl/Lef complex
is active and able to stimulate expression of its target
genes. Although we did not observe a direct effect of
Fig. 8. HCC cells upregulate cyclin D1 mRNA expression after
SDF-1 and HGF stimulation. HCC cells were cultured in the presence
or absence of SDF-1 and HGF and cyclin D1 expression was
measured by qRT-PCR. Black parts of bars represent levels of cyclin
D1 expression in unstimulated cells. Gray parts of bars show the
increase in comparison to control. Experiment was repeated twice
with similar results.
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SDF-1 on cell proliferation in this study, an activation
of cyclin D1 after SDF-1 stimulation confirms that SDF-
1 in fact can enhance cell proliferation in other ex-
perimental models [19, 27, 34]. In some colon tumors in
which APC mutation occurs, the regulation of β-cate-
nins is disrupted and they accumulate gradually in the
nucleus [20]. This nuclear accumulation of β-catenins is
responsible for expansion of the tumors . Whether accu-
mulation of β-catenins and activation of transcription
complexes after stimulation with SDF-1 may be respon-
sible for activation of other tumor-associated genes in
HCC cells, is currently under investigation in our labor-
atory. 
In this paper we have shown that CXCR4 receptor is
functional and that binding of SDF-1 stimulates cell
movement, cytoskeleton reorganization and gene acti-
vation. We have also demonstrated that SDF-1 can
synergize with HGF in promoting tumor cell motility.
The excessive tumor cell motility is a hallmark of the
aggressive and metastatic tumor phenotype. We believe
that the SDF-1-CXCR4 axis could be responsible for
cervical carcinoma tumor invasion into adjacent tissue
and subsequently into distant organs that secret SDF-1
such as bones, lymph nodes and liver. According to our
results, we think that this axis could be a potential target
for antitumor therapies. Several small molecule inhibi-
tors of this axis have been already developed [7, 29] and
could be used in preventing the dissemination of cervical
carcinoma cells. This possibility is also currently inves-
tigated in our laboratory. 
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